Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Anagrelide-induced pulmonary arterial hypertension": a rare case of drug-induced pulmonary arterial hypertension.1 passage
• A case of pulmonary arterial hypertension associated with adult hemophagocytic lymphohistiocytosis.1 passage
• A case of reversible pulmonary arterial hypertension associated with incontinentia pigmenti.1 passage
• A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension.1 passage
• A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib.1 passage
• A novel BMPR2 mutation with widely disparate heritable pulmonary arterial hypertension clinical phenotype.1 passage
• Abnormalities in hyperpolarized (129)Xe magnetic resonance imaging and spectroscopy in two patients with pulmonary vascular disease.1 passage
• Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?1 passage
• Acute pulmonary hypertension caused by tumor embolism: a report of two cases.1 passage
• Addition of a bilateral access form of peripheral extracorporeal membrane oxygenation rescued a patient with idiopathic pulmonary arterial hypertension who developed circulatory collapse immediately after childbirth.1 passage
• Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy.1 passage
• An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature.1 passage
• Autopsy study of pulmonary capillary hemangiomatosis with inflammatory cell infiltration into the myocardium.1 passage
• Balloon atrial septostomy as initial therapy in pediatric pulmonary hypertension.1 passage
• Carfilzomib-associated pulmonary arterial hypertension in multiple myeloma.1 passage
• Case series of 5 patients with end-stage renal disease with reversible dyspnea, heart failure, and pulmonary hypertension related to arteriovenous dialysis access.1 passage
• Case series of seven women with uterine fibroids associated with venous thromboembolism and chronic thromboembolic disease.1 passage
• Catheter-directed therapy for submassive pulmonary embolism after unsuccessful systemic thrombolysis.1 passage
• Chronic thromboembolic pulmonary hypertension following pulmonary embolism with a right ventricular thrombus: A report of two cases.1 passage
• Chronic thromboembolic pulmonary hypertension mimicking coronary artery disease.1 passage
• Chronic thromboembolic pulmonary hypertension, pregnancy, and a pulmonary endarterectomy: a rare challenge.1 passage
• Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension.1 passage
• Diazoxide-associated pulmonary hypertension in a patient with noncompaction cardiomyopathy.1 passage
• Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2.1 passage
• Evidence of pulmonary arterial hypertension in two patients with common variable immunodeficiency.1 passage
• First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension.1 passage
• First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension.1 passage
• Gestational pulmonary arterial hypertension.1 passage
• Hemodynamic response to treatment of iron deficiency anemia in pulmonary arterial hypertension: longitudinal insights from an implantable hemodynamic monitor.1 passage
• Idiopathic hypereosinophilic syndrome with pulmonary hypertension.1 passage
• Imatinib for right heart failure in COPD.1 passage
• Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension.1 passage
• Implantable system for treprostinil and lung transplantation: case series from delivery for pulmonary arterial hypertension study.1 passage
• Incident pulmonary arterial hypertension associated with Bosutinib.1 passage
• Insights on pulmonary tumor thrombotic microangiopathy: a seven-patient case series.1 passage
• Intravenous treprostinil via an implantable pump in pediatric pulmonary arterial hypertension.1 passage
• Isolated large vessel pulmonary vasculitis leading to pulmonary artery aneurysm formation: a case report and literature review.1 passage
• Late-onset pulmonary arterial hypertension in repaired D-transposition of great arteries: an uncommon complication.1 passage
• Left main bronchus compression due to main pulmonary artery dilatation in pulmonary hypertension: two case reports.1 passage
• Left main coronary artery compression in pulmonary arterial hypertension.1 passage
• Liver transplantation in a patient with hereditary haemorrhagic telangiectasia and pulmonary hypertension.1 passage
• Magnetic resonance lymphangiography in group 1 paediatric pulmonary arterial hypertension.1 passage
• Mate-pair sequencing identifies a cryptic1 passage
• MitraClip procedure as 'bridge to list', the ultimate therapeutic option for end-stage heart failure patients not eligible for heart transplantation due to severe pulmonary hypertension.1 passage
• Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and1 passage
• Never too old for congenital heart disease: sinus venosus atrial septal defect with anomalous pulmonary venous return in an octogenarian.1 passage
• Nutritional ketosis to treat pulmonary hypertension associated with obesity and metabolic syndrome: a case report.1 passage
• Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol.1 passage
• Oral treprostinil for the treatment of pulmonary arterial hypertension in patients transitioned from parenteral or inhaled prostacyclins: case series and treatment protocol.1 passage
• Palliative balloon atrial septostomy in two pediatric patients with severe pulmonary arterial hypertension requiring extracorporeal membrane oxygenation support.1 passage
• Peripheral pulmonary stenosis with Noonan syndrome treated by balloon pulmonary angioplasty.1 passage
• Pregnancy as a possible trigger for heritable pulmonary arterial hypertension.1 passage
• Pulmonary arterial hypertension and acute respiratory distress syndrome in a patient with adult-onset stills disease.1 passage
• Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature.1 passage
• Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease.1 passage
• Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing.1 passage
• Pulmonary endarterectomy in a 12-year-old boy with multiple comorbidities.1 passage
• Pulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: a case series.1 passage
• Pulmonary hypertension associated with neurofibromatosis type 2.1 passage
• Pulmonary hypertension complicating multiple myeloma.1 passage
• Pulmonary micro-tumor emboli resulting in paradoxical emboli: a case report.1 passage
• Pulmonary thromboendarterectomy in the setting of a mediastinal venous malformation with a congenitally absent left subclavian vein.1 passage
• Pushing the envelope: a treat and repair strategy for patients with advanced pulmonary hypertension associated with congenital heart disease.1 passage
• Rapid dynamic bedside assessment of pulmonary perfusion defect by electrical impedance tomography in a patient with acute massive pulmonary embolism.1 passage
• Real-world experience using combination therapy with riociguat and risk assessment using REVEAL Lite 2.0 in patients with pulmonary arterial hypertension.1 passage
• Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy.1 passage
• Replacing a phosphodiesterase-5 inhibitor with riociguat in patients with connective tissue disease-associated pulmonary arterial hypertension: a case series.1 passage
• Resolution of myelofibrosis-associated pulmonary arterial hypertension following allogeneic hematopoietic stem cell transplantation.1 passage
• Reversible pulmonary artery perfusion abnormalities in the postpartum period as a precursor to the development of pulmonary arterial hypertension.1 passage
• Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series.1 passage
• Selective pulmonary vasodilation improves ventriculovascular coupling and gas exchange in a patient with unrepaired single-ventricle physiology.1 passage
• Severe reversible pulmonary hypertension in smoldering multiple myeloma: two cases and review of the literature.1 passage
• Severe thrombocytopenia in patients with idiopathic pulmonary arterial hypertension provided several strategies for lung transplantation.1 passage
• Successful depiction of systemic collateral supply to pulmonary artery in CTEPH using time-resolved 4D CT angiography: a case report.1 passage
• Successful treatment of aortic root abscess in a patient with pulmonary arterial hypertension.1 passage
• Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report.1 passage
• Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.1 passage
• The optimization of iloprost inhalation under moderate flow of oxygen therapy in severe pulmonary arterial hypertension.1 passage
• The wide spectrum of β-thalassaemia intermedia-induced pulmonary hypertension: two case reports on the possible role of specific pulmonary arterial hypertension therapy.1 passage
• Transition from parenteral prostacyclins to selexipag: safety and feasibility in selected patients.1 passage
• Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension.1 passage